HILLESTAD PHARMACEUTICALS USA, INC. – Trademark Portfolio
Entity Type: 03
HILLESTAD PHARMACEUTICALS USA, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DIALYVITE, HILLESTAD, and SUMMIT GOLD. The owner is based in WOODRUFF, WI.
P.O. Box 1700
WOODRUFF, WI 54568
Showing of trademarks Trademarks
Trademark Classifications
HILLESTAD PHARMACEUTICALS USA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does HILLESTAD PHARMACEUTICALS USA, INC. have?
HILLESTAD PHARMACEUTICALS USA, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does HILLESTAD PHARMACEUTICALS USA, INC. file in?
HILLESTAD PHARMACEUTICALS USA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HILLESTAD PHARMACEUTICALS USA, INC.'s most well-known trademarks?
HILLESTAD PHARMACEUTICALS USA, INC.'s registered trademark portfolio includes well-known marks such as DIALYVITE, HILLESTAD, and SUMMIT GOLD. These are among 3 currently registered trademarks in the portfolio.
What is HILLESTAD PHARMACEUTICALS USA, INC.'s trademark registration success rate?
HILLESTAD PHARMACEUTICALS USA, INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.